{"id":"https://openalex.org/W2188569672","doi":null,"title":"A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z.","display_name":"A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z.","publication_year":1993,"publication_date":"1993-01-01","ids":{"openalex":"https://openalex.org/W2188569672","mag":"2188569672","pmid":"https://pubmed.ncbi.nlm.nih.gov/8418252"},"language":"en","primary_location":{"id":"pmid:8418252","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8418252","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065439929","display_name":"Makiko Suehiro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Suehiro","raw_affiliation_strings":["Division of Nuclear Medicine and Radiation Health Sciences, Johns Hopkins Medical Institutions, Baltimore, MD 21205-2179"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nuclear Medicine and Radiation Health Sciences, Johns Hopkins Medical Institutions, Baltimore, MD 21205-2179","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072542113","display_name":"Ursula Scheffel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"U Scheffel","raw_affiliation_strings":["Johns Hopkins University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021803422","display_name":"Robert F. Dannals","orcid":"https://orcid.org/0000-0002-5483-5914","observed_orcids":["https://orcid.org/0000-0002-5483-5914"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R F Dannals","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005602721","display_name":"Hayden T. Ravert","orcid":"https://orcid.org/0000-0002-5076-8961","observed_orcids":["https://orcid.org/0000-0002-5076-8961"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H T Ravert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109191684","display_name":"George A. Ricaurte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G A Ricaurte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110016509","display_name":"Henry N. Wagner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H N Wagner","raw_affiliation_strings":["Johns Hopkins University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.0237,"has_fulltext":false,"cited_by_count":96,"citation_normalized_percentile":{"value":0.97144922,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"34","issue":"1","first_page":"120","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.7782999873161316,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.7782999873161316,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.14659999310970306,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serotonin-transporter","display_name":"serotonin transporter","score":0.5070000290870667},{"id":"https://openalex.org/keywords/serotonin-uptake-sites","display_name":"serotonin uptake sites","score":0.6850000023841858},{"id":"https://openalex.org/keywords/pet-radiotracer","display_name":"PET radiotracer","score":0.8349999785423279},{"id":"https://openalex.org/keywords/serotonergic-neurotransmission","display_name":"serotonergic neurotransmission","score":0.796999990940094},{"id":"https://openalex.org/keywords/neuroimaging","display_name":"neuroimaging","score":0.38100001215934753}],"concepts":[{"id":"https://openalex.org/C67847695","wikidata":"https://www.wikidata.org/wiki/Q626478","display_name":"Radioligand","level":3,"score":0.7550437450408936},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.7401578426361084},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7334626317024231},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.6882161498069763},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.5499224662780762},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5039827227592468},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4215278923511505},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4041456878185272},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.320631206035614},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3001362383365631},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2838238477706909},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1368502676486969},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.12489703297615051},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002250","descriptor_name":"Carbon Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003891","descriptor_name":"Desipramine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014055","descriptor_name":"Tomography, Emission-Computed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014179","descriptor_name":"Neurotransmitter Uptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8418252","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8418252","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","raw_type":"Journal Article"},{"id":"mag:2188569672","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8418252","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G169131258","display_name":"NEURORECEPTOR BINDING IN MAN","funder_award_id":"P01NS015080","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G5214361129","display_name":"|","funder_award_id":"R01DA006309","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1969356937","https://openalex.org/W1973455611","https://openalex.org/W1988276999","https://openalex.org/W1999261054","https://openalex.org/W2011918414","https://openalex.org/W2014166296","https://openalex.org/W2041524883","https://openalex.org/W2044831632","https://openalex.org/W2052646227","https://openalex.org/W2080359305","https://openalex.org/W2084117060","https://openalex.org/W2100187986","https://openalex.org/W2121540689","https://openalex.org/W2138691656","https://openalex.org/W2284449950","https://openalex.org/W2950891856"],"related_works":["https://openalex.org/W2029725188","https://openalex.org/W1983638695","https://openalex.org/W2045180056","https://openalex.org/W1906659553","https://openalex.org/W1923593445","https://openalex.org/W2188283623","https://openalex.org/W2052646227","https://openalex.org/W2012436309","https://openalex.org/W1990550530","https://openalex.org/W2035250919"],"abstract_inverted_index":{"A":[0],"radioligand":[1],"for":[2,26,38,202,215],"imaging":[3,217],"central":[4],"serotonin":[5,53],"(5-hydroxytryptamine;":[6],"5-HT)":[7],"uptake":[8,55,93,134,162,204,220],"sites":[9,135,221],"by":[10,152],"positron":[11],"emission":[12],"tomography":[13],"(PET)":[14],"has":[15],"yet":[16],"to":[17,74,110,146],"be":[18,24],"developed.":[19],"Such":[20],"a":[21,165,185,213],"tracer":[22],"would":[23],"useful":[25],"the":[27,39,47,50,65,147,172,192,197,223],"study":[28],"of":[29,41,49,67,91,119,132,143,156,171,175,178,196,218],"normal":[30],"and":[31,64,99,106,141,160,164,207],"altered":[32],"serotonergic":[33,42],"neurotransmission":[34],"as":[35,37,212],"well":[36,128],"detection":[40],"neurotoxicity.":[43],"This":[44],"paper":[45],"describes":[46],"labeling":[48],"highly":[51],"potent":[52],"(5-HT)":[54],"blocker,":[56],"McN-5652-Z":[57,180],"(trans-1,2,3,5,6,10":[58],"beta-hexahydro-6-[4-(methylthio)phenyl]pyrrolo-[2,1-a]-isoquinoline;":[59],"racemic":[60],"mixture),":[61],"with":[62,72,88,108,129],"11C":[63],"evaluation":[66],"this":[68],"radiotracer":[69,198,214],"in":[70,76,86,121,184,193,222],"rodents":[71],"respect":[73],"its":[75],"vivo":[77,194],"binding":[78,145,183,195],"characteristics.":[79],"In":[80],"mouse":[81],"brain,":[82],"11C-McN-5652-Z":[83,182,209],"accumulated":[84],"rapidly":[85],"regions":[87],"high":[89],"densities":[90],"5-HT":[92,133,148,203,219],"sites.":[94],"The":[95,117,139],"ratio":[96],"between":[97],"hypothalamus":[98],"cerebellum":[100],"was":[101,199],"1.5:1":[102],"at":[103,112,124],"15":[104],"min":[105,114,126],"increased":[107],"time":[109],"4.6:1":[111],"90":[113],"after":[115],"injection.":[116],"distribution":[118],"11C-McN-5652":[120,144],"rat":[122],"brain":[123],"60":[125],"correlated":[127],"regional":[130],"concentrations":[131],"(r":[136],"=":[137],"0.86).":[138],"specificity":[140],"selectivity":[142],"transporter":[149],"were":[150],"tested":[151],"preinjecting":[153],"blocking":[154],"doses":[155,177],"known":[157],"5-HT,":[158],"dopamine":[159],"norepinephrine":[161],"inhibitors,":[163],"5-HT2":[166],"receptor":[167],"blocker":[168],"before":[169],"injection":[170],"radiotracer.":[173],"Preinjection":[174],"increasing":[176],"unlabeled":[179],"inhibited":[181],"dose-dependent":[186],"fashion.":[187],"These":[188],"results":[189],"suggest":[190],"that":[191,208],"specific,":[200],"selective":[201],"sites,":[205],"saturable":[206],"holds":[210],"promise":[211],"PET":[216],"mammalian":[224],"brain.":[225]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}